Analysts' Actions: LB MYGN SP EXPE

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

L Brands
( LB) was downgraded to hold at TheStreet Ratings.

Myriad Genetics
( MYGN) was downgraded from market perform to underperform at JMP Securities. Twelve-month price target is $15. BRCA pricing is lower than expected, JMP Securities said.

SP Plus
( SP) was upgraded to buy at TheStreet Ratings.

[Read: 4 Stocks Ready for Breakouts]

Stock Comments / EPS Changes

Expedia's
( EXPE) 12-month price target was raised at Cantor Fitzgerald. Shares are now seen reaching $75. Checks point to higher site visitation in recent months, Cantor Fitzgerald said. Buy rating.

[Read: What Supplemental Health Care Has Been Costing Us]

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

If you liked this article you might like

Stock Markets Are Booming Again but Panties Prices Continue to Plunge

Stock Markets Are Booming Again but Panties Prices Continue to Plunge

Facebook and Microsoft Just Watched Their Stocks Make a Bullish Signal

Facebook and Microsoft Just Watched Their Stocks Make a Bullish Signal

8 Stocks That Are Ready to Change Direction

8 Stocks That Are Ready to Change Direction

Good Reasons for Stocks to Soar: Cramer's 'Mad Money' Recap (Tuesday 12/2/18)

Good Reasons for Stocks to Soar: Cramer's 'Mad Money' Recap (Tuesday 12/2/18)

Jim Cramer: Stocks Are on Fire For Good Reasons

Jim Cramer: Stocks Are on Fire For Good Reasons